Derek Kelaita

About Derek Kelaita

Twenty years of business/corporate development experience negotiating in-licensing, out-licensing transactions as well as strategic collaborations for public/private biopharmaceutical companies. Responsible for licensing/M&A transactions valued at over $1 billion in multiple therapeutic areas including: CNS orphan drugs (ArmaGen), immunotherapy (AnaptysBio), metabolic/diabetes (Cebix), dental (Novalar), infectious disease (Nventa), oncology (Dendreon) and cardiovascular disease (Corvas). Brings a history of successfully directing cross-functional teams of senior executives to achieve business development objectives and provides strategic and tactical advice in the areas of corporate/business development, investor relations, public relations, intellectual property, finance and market research.

Experience

1. Vice President, Business Development

   Lineage Cell Therapeutics

   Aug 2019 — Present · Carlsbad, CA, US

Education

• University of San Diego

  M.B.A., New Venture Management

  1997 — 1999

• University of California, Berkeley

  B.A., Molecular and Cell Biology

  1990 — 1994

Skills

• Negotiation
• Biotechnology
• Corporate Development
• Strategy
• Diabetes
• Lifesciences
• In-Licensing
• Oncology
• Life Sciences
• Due Diligence
• Out-Licensing
• Clinical Development
• Licensing
• Commercialization
• Infectious Diseases
• Drug Development
• Biopharmaceuticals
• Pharmaceutical Industry
• Cross-Functional Team Leadership
• Intellectual Property
• Mergers & Acquisitions